Whitehawk Therapeutics/$WHWK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Whitehawk Therapeutics
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
Ticker
$WHWK
Sector
Primary listing
Employees
23
Headquarters
Website
WHWK Metrics
BasicAdvanced
$196m
-
-$0.33
0.62
-
Price and volume
Market cap
$196m
Beta
0.62
52-week high
$4.48
52-week low
$1.43
Average daily volume
212k
Financial strength
Current ratio
10.263
Quick ratio
10.035
Profitability
EBITDA (TTM)
-114.321
Gross margin (TTM)
-1,183.74%
Net profit margin (TTM)
-288.26%
Operating margin (TTM)
-1,601.12%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
-64.66%
Return on equity (TTM)
-21.82%
Valuation
Price to revenue (TTM)
36.032
Price to book
1.44
Price to tangible book (TTM)
1.44
Price to free cash flow (TTM)
-2.627
Free cash flow yield (TTM)
-38.06%
Free cash flow per share (TTM)
-1.583
Growth
Revenue change (TTM)
-72.50%
Earnings per share change (TTM)
-85.88%
3-year revenue growth (CAGR)
-22.27%
3-year earnings per share growth (CAGR)
-50.16%
What the Analysts think about WHWK
Analyst ratings (Buy, Hold, Sell) for Whitehawk Therapeutics stock.
WHWK Financial Performance
Revenues and expenses
WHWK Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Whitehawk Therapeutics stock?
Whitehawk Therapeutics (WHWK) has a market cap of $196M as of April 29, 2026.
What is the P/E ratio for Whitehawk Therapeutics stock?
The price to earnings (P/E) ratio for Whitehawk Therapeutics (WHWK) stock is 0 as of April 29, 2026.
Does Whitehawk Therapeutics stock pay dividends?
No, Whitehawk Therapeutics (WHWK) stock does not pay dividends to its shareholders as of April 29, 2026.
When is the next Whitehawk Therapeutics dividend payment date?
Whitehawk Therapeutics (WHWK) stock does not pay dividends to its shareholders.
What is the beta indicator for Whitehawk Therapeutics?
Whitehawk Therapeutics (WHWK) has a beta rating of 0.62. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.